494
Views
170
CrossRef citations to date
0
Altmetric
Research Article

Interpretation and Clinical Significance of Alkaline Phosphatase Isoenzyme Patterns

&
Pages 197-293 | Published online: 27 Sep 2008

References

  • Suzuki U., Yoshimura K, Takaishi M. Ueber ein Enzym “Phytase” das “Anhydroxo-oxymethylen-diphosphosaiire” spaltet. Bull Coll Agric Tokyo Imp Univ. 1907; 7: 503–12
  • Weiss M. J., Henthom P. S., Lafferty M. A., et al. Isolation and characterization of cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci USA 1986; 83: 7182–6
  • Weiss M. J., Ray K., Henthom P. S., et al. Structure of the human liver/bone/kidney alkaline phosphatase. gent. J Biol Chem 1988; 263: 12002–10
  • Millan J. L. Molecular cloning and sequence analysis of human placental alkaline phosphatase. J Biol Chem. 1986; 261: 3112–5
  • Millan J. L. Oncodevelopmental expression and structure of alkaline phosphatase genes. Anticancer Res. 1988; 8: 995–1004
  • Berger J., Garattini E., Hua J-C, Udenfriend S. Cloning and sequencing of human intestinal alkaline phosphatase cDNA. Proc Natl Acad Sci USA 1987; 84: 695–8
  • Robison R. The possible significance of hexosophosphoric esters in ossification in vitro. Biochem 1923; 17: 286–93
  • Haije W. G., De Jong M. Iso-enzyme patterns of serum alkaline phosphatase in agar-gel electrophoresis and their clinical significance. Clin Chim Acta. 1963; 8: 620–3
  • Jennings R. C., Brocklehurst D, Hirst M. A comparative study of alkaline phosphatase enzymes using starch-gel electrophoresis and Sephadex gel-filtration with special reference to high molecular weight enzymes. Clin Chim Acta. 1970; 30: 509–17
  • Smith M., Weiss M. J., Griffin C. A., et al. Regional assignment of the gene for human liver/bone/ kidney alkaline phosphatase to chromosome Ip36.1-p34. Genomics. 1988; 2: 139–43
  • Komoda T., Sakagishi Y. The function of the carbohydrate moiety and alteration of carbohydrate composition in human alkaline phosphatase isoenzymes. Biochim Biophys Acta. 1978; 523: 395–406
  • Griffin C. A., Smith M., Henthom P. S., et al. Human placental and intestinal alkaline phosphatase genes map to 2q34-q37. Am J Hum Genet. 1987; 41: 1025–34
  • Watanabe K., Fishman W. H. Application of the stereospecific inhibitor L-phenylalanine to enzymorphology of intestinal alkaline phosphatase. J Histochem Cytochem. 1964; 12: 252–60
  • Pfleiderer G., Baier M., Mondorf A. W., et al. Change in alkaline phosphatase isoenzyme pattern in urine as possible marker for renal disease. Kidney Int. 1980; 17: 242–9
  • Verpooten G. F., Nouwen E. J., Hoylaerts M. F., et al. Segment specific localization of intestinal type ALP in human kidney. Kidney Int. 1989; 36: 617–25
  • Vockley J., Meyer LJ, Harris H. Differentiation of human adult and fetal intestinal alkaline phosphatases with monoclonal antibodies. Am. J. Hum Genet. 1984; 36: 987–1000
  • Mueller H. D., Leung H, Stinson R. A. Different genes code for alkaline phosphatases from human fetal and adult intestine. Biochem Biophys Res Commun. 1985; 126: 427–33
  • Higashino K., Kudo S., Ohtani R., et al. A hepatoma-associated alkaline phosphatase, the Kasahara isozyme, compared with one of the isozymes of FL amnion cells. Ann NY Acad Sci. 1975; 259: 337–46
  • Higashino K., Muratani K., Hade T., et al. Gene structure of alkaline phosphatases: purification and some properties of the fast migrating alkaline phosphatase in FL-amnion cells (the Kasahara isoenzyme) and its cDNA cloning. Clin Chim Acta. 1989; 186: 151–64
  • Martin D., Tucker D. F., Gorman P., et al. The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Genet. 1987; 51: 145–52
  • Raimondi E., Talarico D., Moro L., et al. Regional mapping of the human placental alkaline phosphatase gene (ALP) to 2q37 by in situ hybridization. Cytogenet Cell Genet. 1988; 47: 98–9
  • Henthorn P. S., Raducha M., Hadesch T., et al. Sequence and characterization of the human intestinal alkaline phosphatase gene. J Biol Chem. 1988; 263: 12011–9
  • Vergote I. B., Abeler V. M., Bormer O. P., et al. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma. Tumor Biol. 1992; 13: 168–74
  • Wilson P. D., Rustin GJS, Peters T. J. The ultrastructural localization of human neutrophil alkaline phosphatase in normal individuals during pregnancy and in patients with chronic granulocytic leukemia. Histochem J. 1981; 13: 31–43
  • Nouwen E. J., Pollet D. E., Eerdekens M. W., et al. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986; 46: 866–76
  • Nouwen E. J., Hendrix P. G., Dauwe S., et al. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol. 1987; 126: 230–42
  • Fishman W. H., Inglis N. R., Green S., et al. Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature (London). 1968; 219: 697–9
  • Millan J. L., Manes T. Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene. Proc Natl Acad Sci USA 1988; 85: 3024–8
  • Fishman W. H. Alkaline phosphatase isozymes: recent progress. Clin Biochem. 1990; 23: 99–104
  • Povinelli C. M., Knoll B. J. Trace expression of the germ-cell alkaline phosphatase gene in human placenta. Placenta. 1991; 12: 663
  • Lowe M. E., Strauss A. W. Expression of a Nagao-type, phosphatidylinositol-glycan anchored alkaline phosphatase in human choriocarcinomas. Cancer. 1990; 50: 3956–62
  • Fishman W. H. Clinical and biological significance of an isoenzyme tumor marker PLAP. Clin Biochem. 1987; 20: 387–92
  • Knoll B. J., Rothblum KN, Longley M. Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases. Gene. 1987; 60: 267–76
  • Knoll B. J., Rothblum KN, Longley M. Nucleotide sequence of the human placental alkaline phosphatase gene. J Biol Chem. 1988; 263: 12020–7
  • Sodawski J. M., Handschumacher M. D., Krishna Murthy H. M., et al. Crystallographic observations of the metal ion triple in the active site region of alkaline phosphatase. J Mol Biol. 1983; 170: 575–81
  • Kim E. E., Wyckoff H. W. Reaction mechanism of alkaline phosphatase based on crystal structures. J Mol Biol. 1991; 218: 449–64
  • Low M. G., Zilversmit D. B. Role of phosphatidylinositol in attachment of alkaline phosphatase to membranes. Biochemistry 1980; 19: 3913–8
  • Low M. G. Biochemistry of the glycosyl-phosphatidylinositol membrane anchors. Biochem J. 1987; 244: 1–13
  • Slein M. W., Logan G. F. Mechanism of action of the toxin of bacillus anthracis. I. Effect in vivo of some blood serum components. J Bacteriol. 1960; 80: 77
  • Chakrabartty A., Stinson R. A. Tetrameric alkaline phosphatase in human liver plasma membranes. Biochem Biophys Res Commun. 1985; 131: 328–35
  • Hawrylak K., Stinson R. A. Tetrameric alkaline phosphatase from human liver is converted to dimers by phosphatidylinositol phospholipase C. FEBS Lett. 1987; 212: 289–91
  • Hawrylak K., Stinson R. A. The solubilization of tetrameric alkaline phosphatase from human liver and its conversion into various forms by phosphatidylinositol phospholipase C or proteolysis. J. Biol Chem. 1988; 263: 14368–73
  • Low M. G., Huang K-S. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Biochem J. 1991; 279: 483–93
  • Fedde K. N., Lane CC, Whyte M. P. Alkaline phosphatase is an ectoenzyme that acts on micro-molar concentrations of natural substrates at physiological pH in human osteosarcoma (SAOS 2) cells. Arch Biochem Biophys. 1988; 264: 400–9
  • Nakamura T., Nakamura K, Stinson R. A. Release of alkaline phosphatase from human osteosarcoma cells by phosphatidylinositol phospholipase C: effect of tunicamycin. Arch Biochem Biophys. 1988; 265: 190–6
  • Howard A. D., Berger J., Gerber L., et al. Characterization of the phosphatidylinositol-glycan membrane anchor of human placental alkaline phosphatase. Proc Natl Acad Sci USA 1987; 84: 6055–9
  • Walter E. I., Roberts W. L., Rosenberry T. L., et al. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. J Immunol. 1990; 144: 1030–6
  • Wong Y. W., Low M. Phospholipase resistance of glycosyl-phosphatidylinositol membrane anchor on human alkaline phosphatase. Clin Chem. 1992; 38: 2517–25
  • Deng J. T., Hoylaerts M. F., Van Hoof V. O., et al. Differential release of human intestinal alkaline phosphatase in duodenal fluid and serum. Clin Chem. 1992; 38: 2532–8
  • Feldbush T. L., Lafrenz D. Alkaline phosphatase on activated B cells. Characterization of the expression of alkaline phosphatase on activated B cells. J Immunol. 1991; 147: 3690–5
  • Low M. G., Saltiel A. R. Structural and functional roles of glycosylphosphatidylinositol in membranes. Science 1988; 239: 268–75
  • Brown D., Waneck G. L. Glycosyl-phosphatidylinositol-anchored membrane proteins. J Am Soc Nephrol. 1992; 3: 895–906
  • McComb R. B., Bowers GN, Posen S. Alkaline phosphatase. Plenum Press, New York 1979
  • Stinson R. A., McPhee JL, Collier H. B. Phosphotransferase activity of human alkaline phosphatases and the role of enzyme Zn2+. Biochim Biophys Acta. 1987; 913: 272–8
  • Chan JRA, Stinson R. A. Dephosphorylation of phosphoproteins of human liver plasma membranes by endogenous and purified liver alkaline phosphatases. J Biol Chem. 1986; 261: 7635–9
  • Coleman J. E., Gettins P. Molecular properties and mechanism of alkaline phosphatase. Zinc enzymes, T. G. Spiro. Wiley-Interscience, New York 1983; Vol. 5.: 153–218
  • Wilson I. B., Dayan J, Cyr K. Some properties of alkaline phosphatase from Escherichia coli. Transphosphorylation. J Biol Chem 1964; 239: 4182–5
  • Williams D. G., Byfield PGH, Moss D. W. Inhibition of human alkaline phosphatase isoenzyme by the affinity reagent Reactive Yellow 13. Enzyme. 1985; 33: 70–4
  • Coleman I. E. Structure and mechanism of alkaline phosphatase. Annu Rev Biophys Biomol Struct. 1992; 21: 441–83
  • Ehle H., Müller E, Hom A. Alkaline phosphatase of the calf intestine hydrolyzes phospholipids. FEBSLett. 1985; 183: 413–6
  • Harris H., Robson E. B. A genetical study of ethanolamine phosphate excretion in hypophosphatasia. Ann Hum Genet. 1959; 23: 421–41
  • Russell RGG. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet. 1965; 2: 461–4
  • Whyte M. P., Mahuren J. D., Vrabel L. A., et al. Markedly increased circulating pyridoxal-5-phosphate levels in hypophosphatasia. Clin Invest 1985; 76: 752–6
  • Millan J. L. Oncodevelopmental alkaline phosphatases: in search of a function. Prog Clin Biol Res. 1990; 344: 453–75
  • Millan J. L. Alkaline phosphatase as a reporter of cancerous transformation. Clin Chim Acta. 1992; 209: 123–9
  • Zackson S. L., Steinberg M. S. A molecular marker for cell guidance information in the axolotl embryo. Dev Biol. 1988; 127: 435–42
  • Madsen N. B., Tuba J. On the source of the alkaline phosphatase in rat serum. J Biol Chem. 1952; 2: 36–53
  • Young G. P., Friedman S., Yedlin S. T., et al. Effect of fat feeding on intestinal alkaline phosphatase activity in tissue and serum. Am J Physiol. 1981; 241: G461–8
  • Langman MJS, Leuthold E., Robson E. B., et al. Influence of diet on the intestinal component of serum alkaline phosphatase in people of different ABO blood groups and secretor status. Nature (London). 1966; 212: 41–3
  • Glickman R. M., Alpers D. H., Drummey G. D., et al. Increased lymph alkaline phosphatase after fat feeding: effect of medium chain triglycerides and inhibition of protein synthesis. Biochim Biophys Acta. 1970; 201: 226–35
  • Day A. P., Feher M. D., Chopra R., et al. Triglyceride fatty acid chain length influences the post prandial rise in serum intestinal alkaline phosphatase activity. Ann Clin Biochem. 1992; 29: 287–91
  • Keiding N. R. The alkaline phosphatase fractions of human lymph. Clin Sci. 1964; 26: 291–7
  • Petitclerc C., Plante G. E. Renal transport of phosphate: role of alkaline phosphatase. Can J Physiol Pharmacol. 1981; 59: 311–23
  • Tenenhouse H. S., Scriver CR, Vizel E. J. Alkaline phosphatase activity does not mediate phosphate transport in the renal-cortical brush-border membrane. Biochem J;. 1980; 190: 473–6
  • Dousa P. T., Kempson S. A. Regulation of renal brush border membrane transport of phosphate. Miner Electrolyte Metab. 1982; 7: 113–21
  • Kempson S. A., Kim J. K., Northrup T. E., et al. Alkaline phosphatase in adaptation to low dietary phosphate intake. Am J Physiol. 1979; 237: E465–73
  • Moog F., Glazier H. S. Phosphate absorption and alkaline phosphatase activity in the small intestine of the adult mouse and of the chick embryo and hatched chick. Comp Biochem Physiol A. 1972; 42: 321–36
  • Shirazi S. P., Beechy RB, Butterworth P. J. The use of potent inhibitors of alkaline phosphatase to investigate the role of the enzyme in intestinal transport of inorganic phosphate. Biochem J. 1981; 194: 803–9
  • Makiya R., Thornell L-E, Stigbrand T. Placental alkaline phosphatase, a GPI-anchored protein. is clustered in clathrin-coated vesicles. Biochem Biophys Res Commun. 1982; 183: 803–8
  • Becq F., Fanjul M., Merten M., et al. Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells. FEBS Lett. 1993; 327: 337–42
  • Catalan R. E., Martinez A. M., Aragones M. D., et al. Insulin action on brain microvessels: effect on alkaline phosphatase. Biochem Biophys Res Commun. 1988; 150: 583–90
  • Rej R., Horder M. Aspartate aminotransferase (glutamate oxaloacetate transaminase). Methods of Enzymatic Analysis, H. U. Bergmeyer, J. Bergmeyer, M Grass. Verlag Chemie, Weinheim 1987; vol. 3.: 416–33
  • Hansen-Smith F. M., Blackwell LH, Joswiak G. R. Expression of muscle capillary alkaline phosphatase is affected by hypoxia. J Appl Physiol. 1992; 73: 776–80
  • Challa V. R., Moody DM, Troost B. T. Brain embolic phenomena associated with cardiopulmonary bypass. J Neurol Sci. 1993; 117: 224–31
  • Weiss M. J., Ray K., Fallon M. D., et al. Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia. Am J Hum Genet. 1989; 44: 686–94
  • Ali S. Y. Cell mediated calcification and matrix vesicles. Amsterdam, Elsevier 1986
  • Morris D. C., Kensaku M., Takaoka K., et al. Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Miner. 1992; 19: 287–98
  • Ali S. Y., Sajdera SW, Anderson H. C. Isolation and characterization of calcifying vesicles from epiphyseal cartilage. Proc Natl Acad Sci, USA 1970; 67: 1513–20
  • Register T. C., McLean F. M., Low M. G., et al. Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. J Biol Chem. 1986; 261: 9354–60
  • Beertsen W., van den Bos T. Calcification of dental collagen by cultured rabbit periosteum: the role of alkaline phosphatase. Matrix. 1989; 8: 159–71
  • Beertsen W., van den Bos T. Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat. J Clin Invest. 1992; 89: 1974–80
  • Makiya R., Stigbrand T. Placental alkaline phosphatase has a binding site for the human immunoglobulin-G Fc portion. Eur J Biochem. 1992; 205: 341–5
  • Hägerstrand I. Distribution of alkaline phosphatase activity in healthy and diseased human liver tissue. Acta Pathol Microbiol Scand A. 1975; 83: 519–26
  • Crofton P. M. Biochemistry of alkaline phosphatase isoenzymes. Crit Rev Clin Lab Sci. 1982; 16: 161–94
  • Bretaudiére J. P., Vassault A., Amsellem L., et al. Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin Chem. 1977; 23: 2263–74
  • Van Belle H. Alkaline phosphatase. II. Conditions affecting the determination of serum total alkaline phosphatase activity. Clin Chem. 1976; 22: 977–81
  • Wallinder H., Angback K., Kahan J., et al. Measurement of alkaline phosphatase activity by Kodak Ektachem 700 XR analyzer compared with other routine analytical methods. Clin Chem. 1989; 35: 328–9
  • Van Hoof V. O., Van Campenhout C. M., De Broe M. E., et al. Variations in measured alkaline phosphatase activity: influence of isoenzymes and buffer systems. Clin Chem. 1990; 36: 2012–3
  • Whitby L. G., Moss D. W. Analysis of heat inactivation curve of alkaline phosphatase isoenzymes in serum. Clin Chim Acta. 1975; 59: 361–7
  • Fishman W. H., Green S, Inglis N. I. L-Phenylalanine: an organ specific, stereospecific inhibitor of human intestinal alkaline phosphatase. Nature (London). 1963; 198: 685–6
  • Fishman W. H., Sie H. G. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta, [.-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia. 1971; 41: 141–67
  • Lin C. W., Fishman W. H. L-Homoarginine: an organ-specific uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem. 1972; 247: 3082
  • Van Belle H. Alkaline phosphatase. I. Kinetics and inhibition by Levamisole of purified isoenzymes from humans. Clin Chem. 1976; 22: 972–6
  • Bahr M., Wilkinson J. H. Urea as a selective inhibitor of human tissue alkaline phosphatases. Clin Chim Acta. 1967; 17: 367–70
  • Birkitt D. J., Conyers RAJ, Neale F. C. et al. Action of urea on human alkaline phosphatases with a description of some automated techniques for the study of enzyme kinetics. Arch Biochem Biophys. 1967; 121: 470–9
  • Price C. P. Multiple forms of human serum alkaline phosphatase: detection and quantitation. Ann Clin Biochem. 1993; 30: 355–72
  • Schoenau E., Herzog KH, Boehles H. J. Clinical relevance of alkaline phosphatase determinations by high performance liquid chromatography. J Clin Chem Clin Biochem. 1986; 24: 641–6
  • Parviainen M. T., Galloway J. H., Towers J. H., et al. Alkaline phosphatase isoenzyme in serum determined by high-performance anion-exchange liquid chromatography with detection by enzyme reaction. Clin Chem. 1988; 34: 2406–9
  • Severini G., Malaguti Aliberti L, Di-Giovannandrea R. Diagnostic aspects of alkaline phosphatase: separation of isoenzymes in normal and pathological human serum by high-performance liquid chromatography. J Chromatogr. 1991; 563: 147–52
  • Magnusson P., Lofman O, Larsson L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr. 1992; 576: 79–86
  • Wieme R. J. Agar gel electrophoresis. Amsterdam, Elsevier 1965
  • Demetriou J. A., Beattie J. M. Electrophoretic separation on agarose thin film of isoenzymes of alkaline phosphatase from human serum and tissue. Clin Chem. 1971; 17: 290–5
  • Hägerstrand I., Skude G. Improved electrophoretic resolution of human serum alkaline phosphatase isoenzymes in agarose gel by Triton X-100. Scand J Clin Lab Invest. 1976; 36: 127
  • Kaplan M. M., Rogers L. Separation of human serum alkaline phosphatase isoenzymes by polyacrylamide gel electrophoresis. Lancet. 1969; 2: 1029–31
  • Fritsche H. A., Adams-Park H. R. High molecular weight isoenzymes of alkaline phosphatase in human serum. Demonstration by cellulose acetate electrophoresis and physico-chemical characterization. Clin ChimAaa. 1974; 52: 81–9
  • Siede W. H., Seiffert U. B. Quantitative alkaline phosphatase isoenzyme determination by electrophoresis on cellulose acetate membranes. Clin Chem. 1977; 23(1)28–34
  • Blum-Skolnik J., Pace F., Miinst G., et al. Isoelectric focusing of serum alkaline phosphatase isoenzymes. Clin Chim Acta 1983; 157–64
  • Sanderink F. J., Arthur Y., Paille F., et al. Micro-scale two-dimensional electrophoresis of alkaline phosphatase from serum. Clin Chem. 1988; 34: 730–5
  • Meyer-Sabellek W. Alkaline phosphatases. Laboratory and clinical implications. J Chromatogr. 1988; 429: 419–44
  • Van Hoof V. O., Lepoutre L. G., Hoylaerts M. F., et al. Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem. 1988; 34: 1857–62
  • Van Hoof V. O., Van Mullem M., De Broe M. E., et al. Comparison of two commercially available systems for the electrophoretic separation of alkaline phosphatase isoenzymes. J Chromatogr. 1993; 646: 235–43
  • Sinha P. K., Bianchi-Bosisioa A., Meyer-Sabellek W., et al. Resolution of alkaline phosphatase isoenzymes in serum by isoelectric focusing in immobilized pH gradients. Clin Chem. 1986; 32: 1264–8
  • Rosendahl K., Waldenlind L, Oinica D. Microheterogeneity of serum alkaline phosphatase isoenzyme as revealed by isoelectric focusing. Clin Chim Acta. 1987; 168: 297–306
  • Griffiths J., Black J. Separation and identification of ALP isoenzymes and isoforms in serum of healthy persons by isoelectric focusing. Clin Chem. 1987; 12: 2171–7
  • Griffiths J. Enzymatic profiles of hepatic disease investigated by ALP isoenzymes and isoforms. Prog Clin Biochem Med. 1989; 8: 63–74
  • Van Hoof V. O., Hoylaerts M. F., Van Mullem M., et al. Identification of intestinal, intestinal variant, and high-Mr alkaline phosphatase with the resolve-ALP isoelectric focusing system. Clin Chem. 1991; 37: 304–5
  • O'Brien J. F., Baskin L. B., Branum E. L., et al (1993) The specificity of alkaline phosphatase isoforms. Biologie prospective. Proceedings of the 8th colloque de Pom-à-Mousson. 1993, M. M. Galteau, G. Siest, J. Henney. John Libbey Eurotext, Paris, 287–90
  • Van Hoof V. O. The isoenzymes of alkaline phosphatase, separation and pattern recognition, basic structure and clinical interest. PhD thesis. University of Antwerp 1992
  • Hendrix P. G., Hoylaerts M. F., Nouwen E. J., et al. Enzyme immunoassay of human placental and germ-cell alkaline phosphatase in serum. Clin Chem. 1990; 36: 1793–9
  • Verpooten G. F., Nuyts G. D., Hoylaerts M. F., et al. Immunoassay in urine of a specific marker for proximal tubular S3 segment. Clin Chem. 1992; 38: 642–7
  • Masuhara K., Suzuki S., Yoshikawa H., et al. Development of a monoclonal antibody specific for human bone alkaline phosphatase. Bone Miner. 1992; 17: 182–6
  • Hill C. S., Wolfert R. L. The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta. 1989; 186: 315–20
  • Garnero P., Delmas P. D. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 1993; 77: 1046–53
  • Panigrahi K., Delmas P., Singer F., et al. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem. 1994; 40: 822–828
  • Deng J. T., Parsons P. G. Solid phase immunoassay for high molecular weight alkaline phosphatase in human sera using a specific monoclonal antibody. Clin Chim Acta. 1988; 176: 291–302
  • Rosalki S. B., Foo A. Y. Effect of Triton X-100 on precipitation of biliary phosphatase by wheat-germ lectin. Clin Chem. 1989; 35: 513
  • Rosalki S. B., Foo A. Y., Burlina A., et al. Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem. 1993; 39: 648–52
  • Hue N., Tilmant C, Ooms H. A. (1993) Quantification of bone alkaline phosphatase in serum by a precipitation method: is this simplified method clinically acceptable. Proceedings of the 8th colloque de Pont-d-Mousson. Biologie prospective. 1993, M. M. Galteau, G. Siest, J Henney. Paris, John Libbey Eurotext, 283–6
  • Schachter H. Glycoproteins: their structure, biosynthesis and possible clinical implications. ClinBiochem. 1984; 17: 3–14
  • Alhadeff J. A. Malignant cell glycoproteins and glycolipids. Crit Rev Oncol Hematol. 1989; 9: 37–107
  • Koyama I., Miura M., Matsuzaki H., et al. Sugar-chain heterogeneity of human alkaline phosphatases: difference between normal and tumourphosphatasemia of infancy. Am J Dis Child. 1985; 139: 736–40
  • Ramasamy I. Affinity electrophoresis of alkaline phosphatase using polyacrylamide gels. Clin Chim Acta. 1991; 199: 243–52
  • Crofton P. M. Wheat-germ lectin affinity electrophoresis for alkaline phosphatase isoforms in children: age-dependent reference ranges and changes in liver and bone disease. Clin Chem. 1992; 38: 663–70
  • Onica D., Sundblad L., Waldenlind L., et al. Characterization of serum alkaline phosphatase isoenzymes by affinity electrophoresis in agarose gel containing lectin combined with agar gel electrophoresis. Scand J Clin Lab Invest. 1987; 47: 239–45
  • Mattiazzo M., Ramasamy I. Wheat germ lectin affinity electrophoresis of serum alkaline phosphatase with commercially available agarose gels. Clin Chem. 1993; 39: 1404–7
  • Moss DW, Edwards R. K. Improved electrophoretic resolution of bone and liver alkaline phosphatases resulting from partial digestion with neuraminidase. Clin Chim Acta. 1984; 143: 177–82
  • Jung K., Pergande M, Klotzek S. Sialidase from different sources compared for electrophoreti-cally separating serum alkaline phosphatase fractions from liver and bone. Clin Chem. 1989; 35: 1955–7
  • Bailyes E. M., Seabrook R. N., Calvin J., et al. The preparation of monoclonal antibodies to human bone and liver alkaline phosphatase and their use in immunoaffinity purification and in studying these enzymes when present in serum. Biochem J. 1987; 244: 725–33
  • Moss D. W. Alkaline phosphatase isoenzymes. Clin Chem. 1982; 28: 2007–16
  • De Broe M. E., Borgers M, Wieme R. J. The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta. 1975; 59: 369–72
  • De Broe M. E., Schetlemans D., Pollet D. E., et al. Methods for identification and quantification of alkaline phosphatase isoenzymes in human serum. Protides Biol Fluids Proc Colloq. 1984; 32: 1021–4
  • Price C. P., Sammons H. G. The nature of the serum alkaline phosphatase in liver disease. J Clin Pathol. 1974; 27: 392–8
  • De Broe M. E., Roels F., Nouwen E. J., et al. Liver plasma membrane: the source of serum high molecular weight alkaline phosphatase in human serum. Hepatology 1985; 5: 118–28
  • Brocklehurst D., Wilde CE, Doar JWH. The incidence and likely origins of serum particulate alkaline phosphatase and lipoprotein-X in liver disease. Clin Chim Acta. 1978; 88: 509–15
  • Brocklehurst D. The alkaline phosphatase-lipoprotein X complex. Clin Chem 1981; 27: 1317–8
  • Koett J., Howell J, Wolf P. L. Clinical significance of an ultrafast alkaline phosphatase isoenzyme. J Clin Pathol. 1979; 32: 1286–92
  • Crofton P. M., Smith A. F. High-molecular-mass alkaline phosphatase in serum and bile: nature and relationship with lipoprotein-X. Clin Chem. 1981; 27: 864–74
  • Van Hoof V. O., Hoylaerts M. F., Geryl H., et al. Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis. Clin Chem. 1990; 36: 875–8
  • Van Hoof V. O., Hoylaerts M. F., Lepoutre L. G., et al (1989) Detection and preliminary characterization of an “intestinal variant” alkaline phosphatase isoenzyme in human serum. Biologie prospective. Proceedings of the 7th colloque de Pont-a-Mousson. 1989, M. M. Galteau, G. Siest, J. Henney. Paris, John Libbey Eurotext, 203–6
  • De Broe M. E., Wieme R. J., Logghe G. N., et al. Spontaneous shedding of plasma membrane fragments by human cells in vivo and in vitro. Clin Chim Acta. 1977; 81: 237–145.
  • Verpooten G. F., Hoylaerts M. F., Nouwen E. J., et al. Human fetal intestinal alkaline phosphatase: molecular heterogeneity and immunological detection in amniotic fluids. Clin Chim Acta. 1989; 186: 225–38
  • Gainer A. L., Stinson R. A. Evidence that alkaline phosphatase from human neutrophils is the same gene product as the liver/kidney/bone isoenzyme. Clin Chim Acta. 1982; 123: 11–7
  • Vergnes H., Grozdca J, Corberand J. Liver- and placenta-like alkaline phosphatase (EC 3.1.3.1.) isoenzymes in normal human neutrophils. Enzyme. 1984; 31: 154–65
  • Rambaldi A., Terao M., Bettoni S., et al. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony stimulating factor. Blood. 1990; 76: 2565–71
  • Kasyapa CSS, Ramanadham M. Alkaline phosphatase activity is expressed only in B lymphocytes committed to proliferation. Immunol Lett. 1992; 31: 111–6
  • Rosalki S. B., Hurst N. P. Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta. 1976; 73: 149–55
  • Rosalki S. B., Foo A. Y. More on transient hyperphosphatasemia of infancy. Clin Chem. 1983; 29: 723
  • Crofton P. M. What is the case of benign transient hyperphosphatasemia? A study of 35 cases. Clin Chem. 1988; 34: 355–40
  • De Broe M. E., Mets T., Leroux-Roels G., et al. Occurrence of immunoglobulin G-alkaline phosphatase complexes in human serum. Ann Intern Med. 1979; 90: 30–5
  • Crofton P. M. Site of alkaline phosphatase attachment in alkaline phosphatase-immunoglobulin G complexes. Clin Chim Acta. 1981; 112: 33–42
  • Remaley A. T., Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem. 1989; 35: 2261–70
  • Leroux-Roels G. G. Alkalische fosfatase immunoglobuline: complexen in humaan serum. PhD thesis. University of Gent, Gent 1981
  • Gorus F. K., De Pree L. Effect of isoenzyme composition on Kodak Ektachem test results for creatine kinase, lactate dehydrogenase, alkaline phosphatase and amylase. Clin Chem. 1990; 36: 685–6
  • Kohno H., Sudo K, Kanno T. Intestinal alkaline phosphatase linked to immunoglobulin G of the kappa type. Clin Chim Acta. 1983; 135: 41–8
  • Hattori Y., Yamamoto K., Urabe C., et al. Frequency of alkaline phosphatase-immunoglobulin complex among diseased and healthy populations. Clin Chim Acta. 1985; 147: 155–8
  • Brisson-Lougarre A., Vergnes H., Grozdea J., et al. New antibody in severe rhesus incompatible pregnancies: IgG-kappa anti-placental alkaline phosphatase. Am J Reprod Immunol. 1989; 19: 151–4
  • Brock DJH, Barron L, Bedgood D. Prenatal diagnosis of cystic fibrosis using a monoclonal antibody specific for intestinal alkaline phosphatase. Prenat Diagn. 1984; 4: 421–6
  • Moss D. W., Whitby L. G. A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum. Clin Chim Acta. 1975; 61: 63–71
  • Widhalm K., Holzl M. Changes of alkaline phosphatase, inorganic phosphorus and total calcium in sera of 11 to 17 year old healthy adolescents and their relationship to growth. J Clin Chem Clin Biochem. 1985; 23: 711–7
  • Rosalki S. B., Foo A. Y. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984; 30: 1182–6
  • Lehmann F. G. Differentiation of human alkaline phosphatases by lectin binding affinity. Klin Wochenschr. 1980; 58: 947–51
  • Clark L. C., Beck A. Plasma “alkaline” phosphatase activity. I. Normative data for growing children. J Pedialr. 1950; 36: 335–41
  • Fleischer G. A., Eickelberg EJ, Elveback L. R. Alkaline phosphatase activity in the plasma of children and adolescents. Clin Chem. 1977; 23: 469–72
  • Schiele F., Henny J., Hitz J., et al. Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem. 1983; 29: 634–41
  • Rodin A., Duncan A., Quartero HWP, et al. Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. J Clin Endocrinol Metab. 1989; 68: 1123–7
  • Bamford K. F., Harris H., Luffman J. E., et al. Semm-alkaline-phosphatase and the ABO blood-groups. Lancet. 1965; 1: 530–1
  • Langman MJS. Constantinopoulus A Boucher IAD. ABO blood groups, secretor status, and intestinal mucosal concentrations of alkaline phosphatase. Nature (London). 1968; 217: 863–5
  • Bayer P. M., Hotschek H, Knoth E. Intestinal alkaline phosphatase and the ABO blood group system – a new aspect. Clin Chim Acta. 1980; 108: 81–7
  • Kuwana T., Rosalki S. B. Intestinal variant alkaline phosphatase in plasma in disease. Chem 1990; 36: 1918–21
  • Hayhoe FGJ, Quaglino D. Phosphatases. Haematological Cytochemistry. Churchill Livingstone, Edinburgh 1988; 124–66
  • Rosner F, Lee S. L. Endocrine relationships of leukocyte alkaline phosphatase. Blood. 1965; 25: 356–68
  • Climie ARW, Henrichs WL, Foster I. J. Neutrophil alkaline phosphatase test. A review with emphasis on findings in pregnancy. Am J Clin Pathol. 1962; 38: 95–103
  • Fishman W. H. Perspectives on alkaline phosphatase isoenzymes. Am J Med. 1974; 56: 617–50
  • Okamoto T., Seo H., Mano H., et al. Expression of human placental alkaline phosphatase in placenta during pregnancy. Placenta. 1990; 11: 319–27
  • Posen S. Alkaline phosphatase. Ann Intern Med. 1967; 67: 183–203
  • Ewen L. M. Separation of alkaline phosphatase isoenzymes and evaluation of the clinical usefulness of this determination. Am J Clin Pathol. 1974; 61: 143–54
  • Briere R. O. Alkaline phosphatase isoenzymes. Crit Rev Clin Lab Sci. 1978; 10: 1–28
  • Posen S., Doherty E. The measurement of serum alkaline phosphatase in clinical medicine. Adv Clin Chem 1981; 165–245
  • Epstein E., Kiechle F. L., Artiss J. D., et al. The clinical use of alkaline phosphatase enzymes. Clin Lab Med. 1986; 6: 491–505
  • Wolf P. L. Clinical significance of increased or decreased serum alkaline phosphatase isoenzymes. Clin Lab Med. 1986; 6: 525–32
  • Harris H. The human alkaline phosphatases: what we know and what we don't known. Clin ChimActa. 1989; 186: 133–50
  • Koo WWK, Succop P, Hambridge M. Serum alkaline phosphatase and serum zinc concentrations in preterm infants with rickets and fractures. Am J Dis Child. 1989; 143: 1342–5
  • Holland P. C., Wilkinson A. R., Diez J., et al. Prenatal deficiency of phosphate, phosphate supplementation, and rickets in very-low-birth weight infants. Lancet. 1990; 335: 697–701
  • Silverberg J. S., Shane E., Clemens T. L., et al. The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects. J Bone Miner Res. 1986; 1: 383–8
  • Semb T. H., Gudmundson C. R., Wetlin N. E., et al. Alkaline phosphatase activity and isoenzymes in experimental fractures. Clin Chim Acta. 1971; 31: 375–80
  • Woodhouse NJY, Fisher M. T., Sigurdsson G., et al. Paget's disease in a 5-year-old: acute response to human calcitonin. Br Med J. 1972; 4: 267–9
  • Kraut J. R., Metrick M., Maxwell N. R., et al. Isoenzyme studies in transient hyper-associated isoenzymes. J Chromatogr. 1987; 413: 65–78
  • Frank U., Kruse K. Evidence for infectious origin of isolated transient hyperphosphatasemia. EurJPaediatr. 1985; 143: 323–4
  • Rathburn J. C. Hypophosphatasia: a new developmental anomaly. Am J Dis Child. 1948; 75: 822–31
  • Whyte M. P. The metabolic basis ofxs inherited disease 6th ed, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. McGraw-Hill, New York 1989; 2843–56., Hypophosphatasia
  • Henthom P. S., Whyte M. P. Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia. Clin Chem. 1992; 38: 2501–5
  • McFarlane J. D., Poorthuis BJHM, Mulivor R. A., et al. Raised urinary excretion of inorganic pyrophosphate in asymptomatic members of a hypophosphatasemia kindred. Clin Chim Acta. 1991; 202: 141–8
  • Weniger M., Stinson R. A., Plenk H., et al. Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia. Acta Pediatr Scand 1989; Suppl 360: 154–60
  • Fedde K. N., Cole DEC, Whyte M. P. Pseudohypophosphatasia: aberrant localization and substrate specificity of alkaline phosphatase in cultured skin fibroblasts. Am J Hum Genet. 1990; 47: 776–83
  • Eastell R., Heath H. The hypoealcemic states. Their differential diagnosis and management Disorders of bone and mineral metabolism, FL Coe, M. Favus. Raven Press, New York 1992; 571–85
  • Crofton P. M. Properties of alkaline phosphatase isoenzymes in plasma of preterm and term neonates. Clin Chem. 1987; 33: 1778–82
  • Crofton P. M., Hume R. Alkaline phosphatase isoenzymes in the plasma of preterm and term infants: serial measurements and clinical correlations. Clin Chem. 1987; 33: 1783–7
  • McLachlan R., Coakley J., Murton L., et al. Plasma intestinal alkaline phosphatase isoenzymes in neonates with bowel necrosis. Clin Pathol 1993; 46: 654–9
  • Schoenau E., Boeswald W., Wanner R., et al. High-molecular-mass (“biliary”) isoenzyme of alkaline phosphatase and the diagnosis of liver dysfunction in cystic fibrosis. Clin Chem. 1989; 35: 1888–90
  • Brock DJH, Bedgwood D., Barron L., et al. Prospective prenatal diagnosis of cystic fibrosis. Lancet. 1985; 1: 1175–8
  • Boué A, Muller F., Nezelof C., et al. Prenatal diagnosis in 200 pregnancies with a l-in-4 risk of cystic fibrosis. Hum Genet. 1986; 74: 288–97
  • Mulivor R. A., Cook D., Muller F., et al. Analysis of fetal intestinal enzymes in amniotic fluid for the prenatal diagnosis of cystic fibrosis. Am J Hum Genet. 1987; 40: 131–6
  • Mabry C. C., Bautista A., Kirk R. F., et al. Familial hyperphosphatasia with mental retardation, seizures, and neurologic deficits. J Pediatr. 1970; 74: 74–85
  • Wilson J. W. Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med. 1979; 301: 983
  • Parker P. H., Ghishan F. K. Asymptomatic familial elevation of serum alkaline phosphatase levels. Am J Dis Child. 1980; 134: 1094–5
  • Cirera N. L., Vivancos L. J., Salazar B. M., et al. Raised serum alkaline phosphatase activity in one family. Arch Intern Med. 1982; 142: 188–9
  • Kruse K. Inherited isolated hyperphosphatasemia. Acta Paediatr Scand. 1983; 72: 833–5
  • Onica D., Rosendahl K, Waldenlind L. Inherited occurrence of a heat stable alkaline phosphatase in the absence of malignant disease. Clin Chim Acta. 1989; 180: 23–34
  • McEvoy M., Skarbanek P., Wright E., et al. Family with raised serum alkaline phosphatase activity in the absence of disease. Br Med J. 1981; 282: 1272
  • Lieverse A. G., van Essen G. G., Beukeveld GJJ, et al. Familial increased serum intestinal alkaline phosphatase: a new variant associated with Gilbert's syndrome. J Clin Pathol. 1990; 43: 125–8
  • Panteghini M. Benign inherited hyperphosphatasemia of intestinal origin: report of two cases and a brief review of the literature. Clin Chem. 1991; 37: 1449–52
  • Van Hoof V. O., Van Oosterom A. T., Lepoutre G. L., et al. Alkaline phosphatase isoenzyme patterns in malignant disease. Clin Chem. 1992; 38: 2546–51
  • Altman R. D. Paget's disease of bone. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 1027–64
  • Franck W. A., Bress N. M., Singer F. R., et al. Rheumatic manifestations of Paget's disease of bone. Am J Med. 1974; 56: 592–603
  • Fogelman I. The bone scan in Paget's disease. Bone scanning in clinical practice, I. Fogelman. Springer-Verlag, Berlin 1987; 89–104
  • Harinck HIJ, Bijvoet OLM, Vellenga CJLR, et al. Relation between signs and symptoms in Paget's disease of bone. Q. J Med 1986; 226: 133–51
  • Delmas P. D., Demiaux B., Malaval L., et al. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int. 1986; 38: 60–1
  • Duda R. J., O'Brien J. F., Katzman J. A., et al. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age and metabolic bone disease. J Clin Endocrinol Metah. 1988; 66: 951–7
  • Stepan J. J., Presl J., Broulik P., et al. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin Endocrinol Metab. 1987; 64: 1079–82
  • Gehron R. P., Bianco P, Termine J. D. The cellular biology and molecular biochemistry of bone formation. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 241–63
  • Nilsson B. E., Westlin N. E. The plasma concentration of alkaline phosphatase, phosphorus and calcium following femoral neck fracture. Acta Orthop Scand. 1972; 43: 504–10
  • Bikle D. D. Bone disease due to nutritional, gastrointestinal and hepatic disorders. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 951–76
  • Demiaux B., Arlot M. E., Chapuy M-C, et al. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab. 1992; 74: 1146–51
  • Pfeilschifter J., Siegrist E., Wüster C., et al. Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol. 1992; 127: 319–23
  • Stepan J. J., Silinkova-Malkova E., Havranek T., et al. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin ChimActa. 1983; 133: 189–200
  • Moro L., Gazzarini C., Crivellari D., et al. Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem. 1993; 39: 131–4
  • Frenay M., Namer M., Boubil J. L., et al. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients. Bull Cancer. 1988; 75: 533–9
  • Desoize B., Amico S., Larbre H., et al. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma. Clin Biochem. 1991; 24: 443–6
  • Nguyen M., Bonneterre J., Hecquet B., et al. Plasma acid and alkaline phosphatase in patients with breast cancer. Anticancer Res. 1991; 11: 831–4
  • Stieber P., Nagel D., Ritzke C., et al. Significance of bone alkaline phosphatase, CA-15–3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma. Eur J Clin Chem Clin Biochem. 1992; 30: 809–14
  • Cooper E. H., Forbes M. A., Hancock A. K., et al. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases. Biomed Pharmacother. 1992; 46: 31–6
  • Amico S., Liehn J-C, Desoize B., et al. Comparison of phosphatase isoenzymes, PAP and PSA with bone scan in patients with prostate carcinoma. Clin Nucl Med. 1991; 16: 643–8
  • Buris W. J. Parathyroid hormone-related protein: structure, function and measurement. Clin Chem. 1992; 11: 2171–83
  • Carmel R., Lau KHW, Baylink D. J., et al. Cobalamine and osteoblast-specific proteins. N Engl J Med. 1988; 319: 70–5
  • Mundy G., Raisz L., Cooper R., et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974; 291: 1041–5
  • Durie BGM, Salmon SE, Mundy G. R. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol. 1981; 47: 21–30
  • Evans C., Galasko C, Ward C. Does myeloma secrete an osteoblast inhibiting factor%. J Bone Jt Surg 1989; 71B: 288–90
  • Bataille R., Chappard D, Klein B. Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am. 1992; 6: 285–95
  • Carlson K., Ljunghall S., Simonsson B., et al. Serum osteocalcin concentrations in patients with multiple myeloma–correlation with disease stage and survival.fe/77. Med 1992; 231: 133–7
  • Williams A. T., Shearer M. J., Oyeyi J. et al. Serum osteocalcin in the management of myeloma. Eur J Cancer. 1993; 29A: 140–2
  • Van Hoof V. O., Houben E., De Bock R., et al. Bone alkaline phosphatase activity in multiple myeloma. Monoclonal gammopathies III Topics in aging research in Europe, J. Radl, B. Van Camp. Rijswijk, Eurage. 1991; Vol. 14: 255–7
  • Delmas P. D., Wilson D., Mann K., et al. Effect of renal function on plasma levels of osteocalcin. J Clin Endocrinol Metab. 1983; 57: 1028–30
  • Bataille R., Delmas P, Sany J. Serum bone gla-protein in multiple myeloma. Journal Title??% 1987; 59: 329–34
  • Gonchoroff D. G., Branum E. L., Cedel S. L., et al. Clinical evaluation of high-performance affinity chromatography for the separation of bone and liver alkaline phosphatase isoenzymes. Clin ChimActa. 1991; 199: 43–50
  • McKenna M. J., Freany R., Casey O. M., et al. Osteomalacia and osteoporosis: evaluation of a diagnostic index. J Clin Pathol. 1983; 36: 245–52
  • Delmas P. D. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone. 1992; 13: S17–21
  • Resch H., Pietschmann P., Woloszczuk W., et al. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest. 1992; 22: 542–5
  • Johnston J. D., Koneru S., Kuwana T., et al. Bone-derived serum enzymes and bone density in perimenopausal Caucasian women. Ann Clin Biochem. 1993; 30: 191–4
  • Colins N., Maher J. Cole M., et al. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q. J Med 1991; 286: 113–22
  • Okesina A. B., Donaldson D, Lascelles P. T. Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy. J Clin Pathol. 1991; 44: 480–2
  • Dent C. E., Richens A., Rowe DJF, et al. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970; 4: 69–72
  • Nijhawan R., Wierzbicki A. S., Tozer R., et al. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. Int J Clin Pharm Res. 1990; 10: 319–23
  • Newsholme E. A., Leech A. R. Biochemistry for the medical sciences. Chichester, John Wiley & Sons 1984; 756., (1 st ed.)
  • Sjödén G., Rosenqvist M., Kriegholm E., et al. Verapamil increases serum alkaline phosphatase in hypertensive patients. Intern Med 1990; 228: 339–42
  • Bogin E., Chagnac A., Jiippner H., et al. Effect of verapamil on plasma parathyroid hormone. J Clin Chem Clin Biochem. 1987; 25: 83–5
  • McCarron D. A., Pingree P. A., Rubin R. J., et al. Enhanced parathyroid function in essential hypertension: a homeostatic response to urinary calcium leak. Hypertension. 1980; 2: 162–8
  • Cimmino M. A., Soave G., Samanta E., et al. Changes in the bone and liver isoenzymes of alkaline phosphatase in rheumatoid arthritis patients with hyperphosphatasemia after treatment with salmon calcitonin. Curr Ther Res. 1991; 50: 239–46
  • Farley J. R., Wergedal JE, Baylink D. J. Fluoride directly stimulates proliferation and alkaline phosphatase activity in bone forming cells. Science 1983; 222: 330–2
  • Lindsay R., Cosman F. Primary osteoporosis. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 831–88
  • Wergedal J. E., Lau K-HW. Human bone cells contain a fluoride sensitive acid phosphatase: evidence that this enzyme functions at neutral pH as a phosphotyrosyl protein phosphatase. Clin Biochem. 1992; 25: 47–53
  • Veron M-H, Couble M-L, Magloire H. Selective inhibition of collagen synthesis by fluoride in human pulp fibroblasts in vitro. Calcif Tissue Int. 1993; 53: 38–44
  • Brixen K., Nielsen H. K., Charles P., et al. Effects of a short course of oral phosphate treatment on serum parathyroid hormone (1–84) and biochemical markers of bone turn-over: a dose-response study. Calcif Tissue Int. 1992; 51: 276–81
  • Hodsman A. B., Fraher L. J. Biochemical responses to sequential human parathyroid hormone and calcitonin in osteoporotic patients. Bone Miner. 1990; 9: 137–52
  • Ramp W. K., Lenz LG, Galvin RJS. Nicotine inhibits collagen synthesis and alkaline phosphatase activity, but stimulates DNA synthesis in osteoblast-like cells. Proc Soc Exp Biol Med. 1991; 197: 36–43
  • Ali N. Beclomethasone and osteocalcin. Br Med J. 1991; 302: 1080
  • Sorva R., Turpeinen M., Juntunen-Backman K., et al. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol. 1992; 90: 808–15
  • Rhone D. P., Mizuno F. M. Profiles of alkaline phosphatase isoenzymes in serum using cellulose acetate electrophoresis and organ specific inhibitors. Am J Clin Pathol. 1973; 59: 531–41
  • Roberts W. M. Variation in the phosphatase activity of blood in disease. Br J Exp Pathol. 1930; 11: 90–5
  • Bims M., Masek B, Auerbach O. The effects of experimental acute biliary obstruction and release on the rat liver. Am J Pathol. 1962; 40: 95–111
  • Kaplan M. M., Righetti A. Induction of rat liver alkaline phosphatase, the mechanism of serum elevation in bile duct obstruction. J Clin Invest. 1970; 49: 508–16
  • Komoda T., Kumegawa M., Yajima T., et al. Induction of rat hepatic and intestinal alkaline phosphatase activity by bile from bile duct-ligated animals. Am J Physiol. 1984; 246: G394–400
  • Ogawa H., Mink J., Hardison WGM, et al. Alkaline phosphatase activity in hematic tissue and serum correlates with amount and type of bile acid load. Lab Invest. 1990; 62: 87–95
  • Okuda H., Obata H., Nakashini T., et al. Quantification of individual serum bile acids in patients with liver diseases using high performance liquid chromatography. Hepato-gastroenterology 1984; 31: 168–71
  • Wulkan R. W., Leijnse B. Alkaline phosphatase and cholestasis. Ann Clin Biochem. 1986; 23: 405–12
  • Hagerstrand I. Enzyme histochemistry of the liver in extrahepatic biliary obstruction. Acta Pathol Microbiol Scand A. 1973; 81: 737–50
  • Yeh C-T, Wei JS, Liaw Y-F. Biliary alkaline phosphatase measured by mini-column chromatography on DEAE-cellulose: application to detection of hepatobiliary diseases. Clin Chem. 1989; 35: 1684–7
  • Kihn L., Dinwoodie A, Stinson R. A. High-molecular-weight alkaline phosphatase in serum has properties similar to the enzyme in plasma membranes of the liver. Am J Clin Pathol. 1991; 96: 470–8
  • Hoerl B. J., Scott R. E. Plasma membrane vesiculation, a cellular response to injury. Virchows ArchB. 1978; 27: 335–45
  • Black P. H. Shedding from normal and cancer cells. N Engl J Med. 1980; 303: 1415–6
  • Crofton P. M., Elton RA, Smith A. F. High molecular weight alkaline phosphatase: a clinical study. Clin Chim Acta. 1979; 98: 263–75
  • Crofton P. M., Smith A. F. High-molecular-mass alkaline phosphatase in serum and bile: physical properties and relationship with other high-molecular-mass enzymes. Clin Chem. 1981; 27: 860–6
  • Nishio H., Sakuma T., Nakamura S. I., et al. Diagnostic value of high molecular weight alkaline phosphatase in detection of hepatic metastasis in patients with lung cancer. Cancer. 1986; 57: 1815–9
  • Viot M., Thyss A., Schneider M., Viot G., Ramaioli A., Cambon P., Lalanne C. Alfa 1 isoenzyme of alkaline phosphatases. Clinical importance and value for the detection of liver metastases. Cancer. 1983; 52: 140–5
  • Viot M., Thyss A., Viot G., Ramaioli A., Cambon P., Schneider M., Lalanne C. M. Comparative study of gamma glutamyl transferase, alkaline phosphatase and its 1 isoenzyme as biological indicators of liver metastases. Clin Chim Acta. 1981; 115: 349–58
  • Karmen C., Mayne P. D., Foo A. Y., Parbhoo S., Rosalki S. B. Measurement of biliary alkaline phosphatase by mini-column chromatography and by electrophoresis and its application to the detection of liver metastases in patients with breast cancer. J Clin Pathol. 1984; 37: 212–21
  • Schut J. M., Dominador P. D. The value of combined determination of high molecular mass API and LP-X in the differential diagnosis of intrahepatic and extrahepatic obstruction. Clin Chim Acta. 1985; 148: 221–7
  • Lawrence S. H., Melnick P. J. Enzymatic activity related to human serum β-lipoprotein: his-tochemical, immunoelectrophoretic and quantitative studies. Proc Soc Exp Biol Med. 1961; 107: 998–1001
  • Weijers RNM, Kruijswijk H, Baak JNM. Purification of an alkaline phosphatase-lipoprotein X complex. Clin Chem. 1980; 26: 604–8
  • Peretz H., Usher H, Graff E. Lack of phosphatase activity in the “ultra-fast” isoenzyme band. Clin Chem. 1986; 32: 1614–5
  • Alpers D. H., Eliakim R, Deschryver-Kecskemeti K. Secretion of hepatic and intestinal alkaline phosphatases: similarities and differences. Clin Chim Acta. 1989; 186: 211–24
  • Desmet V. J. Modulation of the liver in cholestasis. Gastroenterol Hepatol 1992; 7: 313–23
  • Fishman W. H., Inglis I, Krant M. J. Serum alkaline phosphatase of intestinal origin in patients with cancer and with cirrhosis of the liver. Clin Chim Acta. 1965; 12: 298–303
  • Wames T. W., Hine P, Kay G. Intestinal alkaline phosphatase in the diagnosis of liver disease. Gut. 1977; 18: 274–8
  • Burlina A., Bugiardini R. Alkaline phosphatase isoenzymes in liver cirrhosis. Enzyme. 1978; 23: 121–6
  • Domar U., Danielsson A., Hirano K., et al. Alkaline phosphatase isoenzymes in non-malignant intestinal and hepatic diseases. Scand J Gastroenterol. 1988; 23: 793–800
  • Stolbach L. L., Krant M. J., Inglis N. R., et al. Correlation of serum L-phenylalanine-sensitive alkaline phosphatase derived from intestine with ABO blood group of cirrhotics. Gastroenterology 1967; 52: 819–27
  • Hardonk M. J., Scholtens H. B. A histochemical study about the zonal distribution of the galac-tose-binding protein in rat liver. Histochemistry 1980; 69: 289–97
  • Scholtens H. B., Hardonk MJ, Meijer DKF. A kinetic study of hepatic uptake of canine intestinal alkaline phosphatase in rat. Liver. 1982; 2: 1–13
  • Schwartz A. L. The hepatic asialoglycoprotein receptor. Crit Rev Biochem. 1984; 16: 207–33
  • Sawamura T., Nakada H., Hazama H., et al. Hyperasialoglycoproteinemia in patients with chronic liver disease and/or liver cell carcinoma. Gastroenterology 1984; 87: 1217–21
  • Mayne P. D., Thakrar S., Rosalki S. B., et al. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity. J Clin Pathol. 1987; 40: 398–403
  • Thyss A., Schneider M., Caldani C., et al. Reevaluation of alkaline phosphatase measurement during Hodgkin's disease by electrophoretic isoenzyme separation. Br J Cancer. 1985; 52: 183–7
  • De Broe M. E., Van Hoof V. O. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin Chem. 1991; 37: 783–41
  • Van Hoof V. O., Nobels F., Amouts P., et al. Isoenzymes of alkaline phosphatase in dialyzed patients. Kidney Int. 1990; 38: 362
  • Tibi L., Chhabra C., Sweeting V. M., et al. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin Chem. 1991; 37: 815–20
  • De Broe M. E., Bosteels V, Wieme R. J. Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Lancet. 1974; 1: 753–4
  • Walker A. W. Intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Clin Chim Acta. 1974; 55: 399–405
  • Stepan J. Pilarova T. Serum alkaline phosphatase during maintenance hemodialysis. Lancet. 1975; 1: 1188–9
  • Skillen A. W., Pierides A. M. Serum alkaline phosphatase isoenzyme patterns in patients with chronic renal failure. Clin Chim Acta. 1977; 80: 339–46
  • Alpers D. H., deSchryver-Kecskemeti K., Goodwin C. L., et al. Intestinal alkaline phosphatase in patients with chronic renal failure. Gastroenterology 1988; 94: 62–7
  • Clark B. L., Oka JA, Weige P. H. Degradation of asialoglycoproteins mediated by the galactosyl receptor system in isolated hepatocytes. J Biol Chem. 1987; 262: 17384–92
  • Docci D., Bilanconi R., Baldrati L., et al. Elevated acute phase reactants in hemodialysis patients. Clin Nephrol. 1990; 34: 88–91
  • Korkor A. B. Reduced binding of [3H]l,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med. 1987; 316: 1573–7
  • Silver J. Regulation of parathyroid hormone synthesis and secretion. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 83–106
  • Sherrard D. J., Andress D. L. Renal osteodystrophy. Diseases of the kidney. 4th ed., R. W. Schrier, C. W. Gottschalk. Little Brown, Boston 1988; 3: 3055–61
  • Siede W. H., Seiffert U. B., Bundschum F., et al. Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy. Clin Nephrol. 1980; 13: 277–81
  • Stepan J. J., Lachmanova J., Strakova M., et al. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis. Bone Miner. 1987; 3: 177–83
  • Andress D. L., Norris K. C., Coburn J. W., et al. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. JV. Engl J Med 1989; 321: 274–9
  • Baker LRI, Abramis LSM, Roe C. J., et al. l,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989; 35: 661–9
  • Urena P., Basile C., Grateau G., et al. Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia. Kidney Int. 1989; 36: 120–6
  • Slatopolsky E., Delmez J. Bone disease in chronic renal failure and after renal transplantation. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 905–34
  • Calne R. Y. Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial. Lancet. 1987; 2: 506–7
  • Rambausek M., Ritz E., Pomer S., et al. Alkaline phosphatase levels in renal transplant recipients receiving cyclosporine or azathioprines/steroids. Lancet. 1988; 1: 247–8
  • Briner V., Landmann J., Brunner F. P., et al. Cyclosporin A induced transient rise in plasma alkaline phosphatase in kidney transplant patients. Transpl Int. 1993; 6: 99–107
  • Aubia J., Masramon J., Serrano S, et al. Bone histology in renal transplant patients receiving cyclosporin. Lancet. 1988; 1: 1048–9
  • Kelly P. J., Sambrook PN, Eisman J. A. Potential protection by cyclosporin against glucocorticoid effects on bone. Lancet. 1989; 2: 1388
  • Moriniére P., Cohen-Solal M., Belbrik S., et al. Disappearance of aluminic bone disease in a long-term asymptomatic dialysis population restricting Al(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminium. Nephron. 1989; S3: 93–101
  • Hodsman A. B., Sherrard D. J., Wong EGC, et al. Vitamin D resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med. 1981; 94: 629–37
  • Llach F., Felsenfeld A. J., Coleman M. D., et al. The natural course of dialysis osteomalacia. Kidney Int 1986; 29 (Suppl. 18): S74–9
  • Smith A. J., Faugére M. C., Abreo K., et al. Aluminum related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol. 1986; 6: 275–83
  • Andress D. L., Maloney N. A., Endres D. B., et al. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J Bone Miner Res. 1986; 1: 391–8
  • Coumot-Witmer G., Zingraff J., Plachot J. J., et al. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int. 1981; 20: 375–85
  • Goodman W. G., Gilligan J, Horst R. Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Invest. 1984; 73: 171–81
  • Sebert J. L., Marie A., Gueris J., et al. Assessment of aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formation. Bone. 1985; 6: 373–5
  • Stammler G., Klooker P., Bommer J., et al. Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patients. Blood Purif. 1985; 3: 192–8
  • Sherrard D. J., Hercz G., Pei Y., et al. The spectrum of bone disease in end-stage renal failure – an evolving disorder. Kidney Int. 1993; 43: 436–42
  • Couttenye M. M., Goodman W. G., Segaert M., et al. Predictive value of low serum bone alkaline phosphatase in the diagnosis of adynamic bone disease. J Am Soc Nephrol. 1993; 3: 672
  • Nuyts G. D., Roels H. A., Verpooten G. F., et al. Intestinal-type alkaline phosphatase in urine as an indicator of mercury induced effects on the S3 segment of the proximal tubule. Nephrol Dial Transplant. 1992; 7: 225–9
  • Hirano K., Koyama I, Stigbrand T. Purification and partial characterization of the placental-like alkaline phosphatase in human lung tissue. Clin Chem Acta. 1989; 186: 265–4
  • Eestermans G., Nouwen E. J., Demey H. E., et al. Human placental alkaline phosphatase and lung injury. Chest. 1987; 92: 961
  • Goldberg D. M., Martin JV, Knight A. H. Elevation of serum alkaline phosphatase activity and related enzymes in diabetes mellitus. Clin Biochem. 1977; 10: 8–11
  • Tibi L., Collier A., Patrick A. W., et al. Plasma alkaline phosphatase isoenzymes in diabetes mellitus. Clin Chim Acta. 1988; 177: 147–56
  • Rosalki S. B., Kuwana T. Anti-asialoglycoprotein receptor antibody and intestinal-origin alkaline phosphatase in plasma in diabetes. Clin Chem. 1991; 37: 589
  • Dodeur M., Coumoul S., Durand D., et al. Diabetes-induced variation in hepatic binding protein. Biochem Biophys Res Commun. 1983; 115: 82–6
  • Salmela P. I., Sotaniemi E. A., Niemi M., et al. Liver function tests in diabetic patients. Diabetes Care. 1984; 7: 248–54
  • Levin M. E., Boisseau VC, Aviolli L. V. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med. 1976; 294: 241–5
  • Wiske P. S., Wentworth S. M., Norton J. A., et al. Evaluation of bone mass and growth in young diabetics. Metabolism. 1982; 31: 848–54
  • Gazzarini C., Stagni N., Pollesello D., et al. Possible mechanism of inhibition of cartilage alkaline phosphatase by insulin. Acta Diabetol Lat. 1989; 26: 321–7
  • Stepan J., Havranek T., Formankova J., et al. Bone isoenzyme of serum alkaline phosphatase in diabetes mellitus. Clin Chim Acta. 1980; 105: 75–81
  • Nuyts G. D., Yaqoob M., Nouwen E. J., et al. Human urinary intestinal ALP as an indicator of S3-segment alterations in incipient diabetic nephropathy. Nephrol Dial Transpl, in press
  • Hodgson HJF, Potter BJ, Jewell D. P. mmune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1977; 29: 187–96
  • Leroux-Roels G. G., Wieme RJ, De Broe M. E. Occurrence of enzyme-immunoglobulin complexes in chronic inflammatory bowel disease. J Lab Clin Med. 1981; 97: 316–21
  • Tozawa T., Satomi M, Shinoyama T. Enzyme-linked immunoglobulin in serum of patients with ulcerative colitis. Saishin Igaku. 1983; 38: 1533–6
  • Crofton P. M., Kilpatrick DC, Leitch A. G. Complexes in serum between alkaline phosphatase and immunoglobulin G: immunological and clinical aspects. Clin Chim Acta. 1981; 111: 257–65
  • Kendall M. J., Cockel R., Becker J., et al. Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction%. Ann Rheum Dis 1970; 29: 537–40
  • Webb J., Whaley K., McSween RMN, et al. Liver disease in rheumatoid arthritis and Sjogren's syndrome. Ann Rheum Dis. 1975; 34: 70–81
  • Aida S. Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity. Ann Rheum Dis. 1993; 52: 511–6
  • Yasmineh W. G., Filipovich AH, Killeen A. A. Serum 5 nucleotidase and alkaline phosphatase – highly predictive liver function tests for the diagnosis of graft-vs.-host disease in bone marrow transplant recipients. Transplantation 1989; 48: 809–14
  • Randolph-Habecker J., Lott A., Tesi J. Alkaline phosphatase isoforms in serum after liver allograft surgery. Clin Chem 1994; 40: 1272–1289
  • Hunter R. J., Pinkerton JHM, Johnston H. Serum placental alkaline phosphatase in normal pregnancy and preeclampsia. Obslet Gynecol. 1970; 36: 536–46
  • Aleem F. A. Total and heat-stable serum alkaline phosphatase in normal and abnormal pregnancies. Obstet Gynecol. 1972; 40: 163–72
  • Holmgren P. A., Stigbrand T., Damber M. G., et al. Serum levels of placental alkaline phosphatase in high-risk pregnancies. Obstet Gynecol. 1979; 54: 631–4
  • Ronin-Walknowska E., Holmgren P. A., von Schoultz B., et al. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies. Gynecol Obstet Invest. 1984; 18: 206–11
  • Balgir P. P. Relationship between placental alkaline phosphatase types and obstetric history of mother. Hum Hered. 1988; 38: 31–5
  • Nakayama Y., Yoshida M, Kitamura M. L-Leucine sensitive, heat-stable alkaline phosphatase isoenzyme detected in a patient with pleuritis carcinomatosa. Clin Chim Acta. 1970; 30: 546–8
  • Sakiyama T., Robinson JC, Chou J. Y. Characterization of alkaline phosphatases from human first trimester placentas. J Biol Chem. 1979; 254: 935–8
  • Hirano K., Domar U., Yamamoto H., et al. Levels of alkaline phosphatase isoenzymes in human seminoma tissue. Cancer Res. 1987; 47: 2543–6
  • De Broe M. E., Pollet D. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum. Clin Chem. 1988; 34: 1955–9
  • Vergote I., Onsrud M, Nustad K. Placental alkaline phosphatase as a tumor marker in ovarian cancer. Obstet Gynecol. 1987; 69: 228–32
  • Millan J. L., Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem. 1983; 136: 1–7
  • McLaughlin P. J., Travers P. J., McDicken I. W., et al. Demonstration of placental and placental-like alkaline phosphatase in nonmalignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. Clin Chim Acta. 1984; 137: 341–8
  • Hamilton-Dutoit S. J., Lou H, Pallesen G. The expression of placental alkaline phosphatase (PLAP) and PLAP-like enzymes in normal and neoplastic human tissues. APMIS. 1990; 98: 797–811
  • Koshida K., Wahren B. Placental alkaline phosphatase in seminoma. Urol Res. 1990; 18: 87–92
  • Pollet D. E., Nouwen D. J., Schelstraete J. B., et al. Enzyme antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts, and its application as a tumor marker. Clin Chem. 1985; 31: 41–5
  • Nozawa S., Udagawa Y., Ohkura H., et al. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies – with special reference for the combination of PLAP and CA54/ 61 assay. Clin Chim Acta. 1989; 186: 275–84
  • Watanabe T., Wada N, Yang C. J. Structural and functional analysis of human germ cell alkaline phosphatase by site-specific mutagenesis. Biochemistry 1992; 31: 3051–8
  • Lange P. H., Millan J. L., Stigbrand T., et al. Placental alkaline phosphatase as a tumor marker for seminoma. Cancer Res. 1982; 42: 3244–7
  • Hustin J., Collette J, Franchimont P. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumors. Int J Androl. 1987; 10: 29–35
  • Maslow W. C., Muensch H. A., Azama F., et al. Sensitive fluorometry of heat-stable alkaline phosphatase (Regan enzyme) activity in serum from smokers and nonsmokers. Clin Chem. 1983; 29: 260–3
  • Ellard G. A., Tucker D. F., Pookin Y. L., et al. Serum placental-like alkaline phosphatase levels and nicotine intake in smokers. Br J Cancer. 1988; 58: 219–21
  • Nielsen O. S., Munro A. J., Duncan W., et al. Is placental alkaline phosphatase (PLAP) a useful marker for seminoma%. Eur J Cancer 1990; 26: 1049–54
  • Nouwen E. J., Buyssens N, De Broe M. E. Heat stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes. Cell Tissue Res. 1990; 260: 321–35
  • Williams G. H., McLaughlin PJ, Johnson P. M. Tissue origin of serum placental-like alkaline phosphatase in cigarette smokers. Clin Chim Acta. 1986; 155: 329–34
  • Latham K. M., Stanbridge E. J. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids. Cancer Res. 1992; 52: 616–22
  • Martinez-Maldonado M., Menendez-Corrada R, Rivera De Sala A. Diagnostic value of alkaline phosphatase in leukocytes. Am J Med Sci. 1964; 248: 175–83
  • Kaplow L. S., Beck R. E. Leukocyte alkaline phosphatase response to surgical stress. Surg Gynecol Obstet. 1964; 119: 97–102
  • Walach N., Kaufman S, Hom Y. Leukocyte alkaline phosphatase in cancer patients. J Cancer Res Clin Oncol. 1981; 100: 69–72
  • Diamant Y. Z., Polishuk W. Z. Leukocyte alkaline phosphatase relative score and basal body temperature as indicators of ovulation during menstrual cycles terminated by normal full-term pregnancies. Fertil Steril. 1979; 31: 405–9
  • Chikkappa G., Stratton S. S. Control of neutrophil alkaline phosphatase synthesis by cytokines in health and disease. Exp Hematol. 1992; 20: 388–90
  • Vergnes H. A., Brisson-Lougarre A., Grozdea J. G., et al. Nuclear localization and characterization of alkaline phosphatase in neutrophils from normal controls and pregnant women. Am J Hematol. 1992; 39: 249–56
  • Vergnes H., Grozdea J., Brisson-Lougarre A., et al. An enzymatic marker in mothers of trisomy 21 children: neutrophil alkaline phosphatase. Enzyme. 1988; 39: 174–80
  • Cuckle H. S. Measuring unconjugated estriol in maternal serum to screen for fetal Down syndrome. Clin Chem. 1992; 38: 1687–9
  • Barsano C. P., Angulo M., Burke S. F., et al. Leukocyte alkaline phosphatase in hypothyroidism and hyperthyroidism. Response to initiation of thyroxin replacement therapy. Metabolism. 1989; 38: 311–4
  • Mitus W. J., Bergna L. J., Mednicoff I. B., et al. Alkaline phosphatase of mature neutrophils in chronic forms of the myeloproliferative syndrome. Am J Clin Pathol. 1958; 30: 285–94
  • Rosenblum D., Petzold S. J. Neutrophil alkaline phosphatase: comparison of enzymes from normal subjects and patients with polycythemia vera and chronic myelogenous leukemia. Blood. 1975; 45: 335–43
  • Travis L. B., Pierre RV, De Wald G. W. Ph I -negative chronic granulocytic leukemia: a nonentity. Am J Clin Pathol. 1985; 85: 186–93
  • Rambaldi A., Terao M., Bettoni S., et al. Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood. 1989; 73: 1113–5
  • Sato N., Asano S., Urabe A. et al. Induction of alkaline phosphatase in neutrophilic granulocytes, a marker of cell maturity, from bone marrow of normal individuals by retinoic acid. Biochem Biophys Res Commun. 1985; 131: 1181–6
  • Burg D. L., Feldbush T. L. Late events in B cell activation: expression of membrane alkaline phosphatase activity. J Immunol. 1989; 142: 381–7
  • Weinstein R. S. Clinical use of bone biopsy. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 455–74
  • Marcus R. Secondary forms of osteoporosis. Disorders of bone and mineral metabolism, FL Coe, M. J. Favus. Raven Press, New York 1992; 889–904
  • Tibi L., Patrick A. W., Leslie P., et al. Alkaline phosphatase isoenzymes in plasma in hyperthyroidism. Clin Chem. 1989; 35: 1427–30
  • Lum G., Marquardt C, Shukri F. K. Hypomagnesemia and low alkaline phosphatase activity in patients' serum after cardiac surgery. Clin Chem. 1989; 35: 664–7
  • Nanji A. A. Decreased serum alkaline phosphatase activity in hypothyroidism: possible relationship to low serum zinc and magnesium. Clin Chem. 1982; 28: 1711–2
  • Yuzbasian-Gurkan V., Brewer G. J., Abrams G. D., et al. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. J Lab Clin Med. 1989; 114: 520–6
  • Yamaguchi M., Ozaki K. A new zinc compound, (3-aIanyI-L-histidinato zinc, stimulates bone growth in weanling rats. Res Exp Med. 1990; 190: 105–10
  • Yamaguchi M., Miwa M. Stimulatory effect of beta-alanyl-L-histidinato zinc on bone formation in tissue culture. Pharmacology 1991; 42: 230–40
  • Segawa Y., Tsuzuike N., Itokazu Y., et al. β-alanyl-L-histidinato zinc prevents hydrocortisone-induced disorder of bone metabolism in rats. Res Exp Med. 1992; 192: 317–22
  • Shaver W. A., Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986; 6: 859–63
  • Willson R. A., Clayson KJ, Leon S. Immeasurable serum alkaline phosphatase activity in Wilson's disease associated with fulminant hepatic failure and hemolysis. Hepatology 1987; 7: 613–5
  • Shaver W. A. Unmeasurable serum alkaline phosphatase activity in Wilson's disease associated with fulminant hepatic failure and hemolysis. Hepatology 1987; 7: 613–5, (reply to Willson R. A., Reference 430)
  • Rej R., Bretaudriére J-P. Effects of metal ions on the measurement of alkaline phosphatase activity. Clin Chem. 1980; 26: 423–8
  • Chappie ILC, Thorpe GHG, Smith G. M., et al. Hypophosphatasia: a family study involving a case diagnosed from gingival crevicular fluid. J Oral Pathol Med. 1992; 21: 426–31
  • Van Hoof V. O., Verpooten G. A., Lepoutre L. G., et al. A computer assisted decision support system for the interpretation of alkaline phosphatase isoenzyme patterns. Clin Chem. 1990; 36: 1014
  • Pohl B., Trendelenburg C. Pro M. D. A diagnostic expert system shell for clinical chemistry test result interpretation. Methods Inf Med. 1988; 27: 111–7
  • Scandinavian, Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest. 1974; 33: 291–303
  • Hendrix P. G. Validation of murine monoclonal antibodies for the in vitro and in vivo identification and detection of human placental and germ cell alkaline phosphatase. PhD thesis, University of Antwerp 1992
  • Assanti R., Hultin H, Visakorpi J. K. Serum alkaline phosphatase in healthy infants. Occurrence of abnormally high values without known cause. Ann Paediatr Fenn. 1966; 12: 139–42
  • Posen S. Transient hyperphosphatasemia of infancy – an insufficiently recognized syndrome. Clin Chem. 1977; 23: 292–4
  • Wieme R. J. More on transient hyperphosphatasemia in infancy: an insufficiently recognized syndrome. Clin Chem. 1978; 24: 520–2
  • Nathan E. Transient hyperphosphatasemia of infancy. Acta Paediatr Scand. 1980; 69: 235–8
  • DeVito G. A. Transient elevation of alkaline phosphatase possibly related to trimethoprim-sulfomethoxazole therapy. Pediatr 1982; 100: 998–9
  • Weiber H., Fex G., Lindberg T., et al. Atypical, anodally migrating alkaline phosphatase isoenzyme in children and its relation to abdominal symptoms. Clin Chem. 1983; 29: 593–5
  • Abbassi V., Colon AR, Schwartz R. H. Benign elevation of serum alkaline phosphatase, transient and persistent variety. Clin Pediatr. 1984; 23: 336–7
  • Arthur LJH, Hill P. G., Attenburrow A. A. Transient hyperphosphatasaemia. Arch Dis Child. 1984; 59: 996–7
  • Holt P. A., Steel AE, Armstrong A. M. Transient hyperphosphatasaemia of infancy following rotavirus infection. J Infect. 1984; 9: 283–5
  • Lockitch G., Pudek MR, Halstead A. C. Isolated elevation of serum alkaline phosphatase. J Pediatr. 1984; 105: 773–5
  • Steinherz P. G., Steinherz L. J., Nisselbaum J. S., et al. Transient, marked unexplained elevation of serum alkaline phosphatase. JAMA 1984; 252: 3289–92
  • Dodds R. Unexplained elevation of serum alkaline phosphatase levels. JAMA 1985; 253: 2645–6
  • Kmse K. Normal bone turnover in isolated hyperphosphatasemia. J Pediatr. 1985; 106: 946–8
  • Shaw P. J., Brueton M. J. Transient hyperphosphatasaemia. Arch Dis Child. 1985; 60: 84–5
  • Vichyanond P. Transient AP elevation in children. Kans Med. 1985; 86: 326–31
  • Cole DEC. Transient hyperphosphatasemia in a child with autosomal recessive vitamin D dependency. Clin Chem. 1986; 32: 1418–9
  • Stein P., Rosalki S. B., Foo A. Y., et al. Transient hyperphosphatasemia of infancy and early childhood; clinical and biochemical features of 21 cases and literature review. Clin Chem. 1987; 33: 313–8
  • Chisholm J. C. Transient, benign serum alkaline hyperphosphatasemia in an adult. JAMA 1986; 78: 338–41
  • Odeh M. M., Bassan H. M. Pleuropneumonia and alkaline phosphatase. Ann Intern Med. 1988; 104: 644
  • Maekawa M., Sugiura K., Azuma Y., et al. Benign transient hyperphosphatasemia in an adult with malignant lymphoma. Clin Chem. 1989; 35: 897
  • Rosalki S. B., Foo A. Y., Went J., et al. Transient hyperphosphatasemia of infancy and childhood in an adult. Clin Chem. 1991; 37: 1137–8
  • Onica D., Torssander J, Waldenlind L. Recurrent transient hyperphosphatasemia of infancy in an adult. Clin Chem. 1992; 38: 1913–5
  • Van Hoof V. O., De Broe M. E. Unpublished results

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.